Status:
COMPLETED
Propofol vs. Midazolam With Propofol for Sedative Endoscopy in Patients With Previous Paradoxical Reaction to Midazolam
Lead Sponsor:
DongGuk University
Conditions:
Sedation
Endoscopy
Eligibility:
All Genders
19+ years
Phase:
PHASE2
Brief Summary
This study is to compare propofol vs. midazolam with propofol for sedative endoscopy in patients with previous paradoxical reaction to midazolam. Patients who meet eligibility criteria will randomly a...
Eligibility Criteria
Inclusion
- History of midazolam-induced paradoxical response
Exclusion
- Failed to obtain informed consent
- Pregnant or breast feeding women
- A severe cardiopulmonary or vascular disease with symptoms
- Cognitive or mental impairment
Key Trial Info
Start Date :
October 19 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
December 20 2020
Estimated Enrollment :
30 Patients enrolled
Trial Details
Trial ID
NCT04072328
Start Date
October 19 2018
End Date
December 20 2020
Last Update
December 29 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Dongguk University Ilsan Hospital
Goyang-si, Gyeonggi-do, South Korea, 10326